4basebio (LON:4BB) Insider Buys £17,280 in Stock

4basebio PLC (LON:4BB) insider Heikki Lanckriet acquired 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were bought at an average price of GBX 576 per share, with a total value of £17,280.

4basebio Price Performance

4basebio stock opened at GBX 569.75 on Friday. 4basebio PLC has a 12-month low of GBX 520 and a 12-month high of GBX 1,220. The stock has a market capitalization of £88.23 million, a P/E ratio of -5.76 and a beta of 1.09. The firm’s 50-day moving average is GBX 600.82 and its two-hundred day moving average is GBX 733.82. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.